BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 23008496)

  • 1. Personalized-medicine trials on the rise.
    Benowitz S
    J Natl Cancer Inst; 2012 Oct; 104(19):1425-6. PubMed ID: 23008496
    [No Abstract]   [Full Text] [Related]  

  • 2. International Cancer Conference: targeted therapies boom expected in 3-5 years.
    Gethins M
    J Natl Cancer Inst; 2011 Oct; 103(20):1491-3. PubMed ID: 21972228
    [No Abstract]   [Full Text] [Related]  

  • 3. [Possibilities and limitations of stratified medicine based on biomarkers and targeted therapies in oncology].
    Ludwig WD
    Z Evid Fortbild Qual Gesundhwes; 2012; 106(1):11-22. PubMed ID: 22325103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
    Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG
    J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NCI-MATCH launch highlights new trial design in precision-medicine era.
    McNeil C
    J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 26142446
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of genomics on personalized cancer medicine.
    Arteaga CL; Baselga J
    Clin Cancer Res; 2012 Feb; 18(3):612-8. PubMed ID: 22298893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personalized lung cancer treatment based on molecular determinants.
    Simon GR
    J S C Med Assoc; 2011 Oct; 107(5):183-4. PubMed ID: 22057801
    [No Abstract]   [Full Text] [Related]  

  • 8. Assessing cancer with a blood draw.
    Azvolinsky A
    J Natl Cancer Inst; 2012 Dec; 104(23):1774-5. PubMed ID: 23213181
    [No Abstract]   [Full Text] [Related]  

  • 9. Making personalized cancer medicine a reality: challenges and opportunities in the development of biomarkers and companion diagnostics.
    Parkinson DR; Johnson BE; Sledge GW
    Clin Cancer Res; 2012 Feb; 18(3):619-24. PubMed ID: 22298894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IGF-1: old growth factor shines as new drug target.
    Garber K
    J Natl Cancer Inst; 2005 Jun; 97(11):790-2. PubMed ID: 15928295
    [No Abstract]   [Full Text] [Related]  

  • 11. Biology-driven phase II trials: what is the optimal model for molecular selection?
    Andre F; Delaloge S; Soria JC
    J Clin Oncol; 2011 Apr; 29(10):1236-8. PubMed ID: 21343554
    [No Abstract]   [Full Text] [Related]  

  • 12. Biospecimen banking: the pathway to personalized medicine for patients with cancer.
    Scolyer RA; Thompson JF
    J Surg Oncol; 2013 Jun; 107(7):681-2. PubMed ID: 23280671
    [No Abstract]   [Full Text] [Related]  

  • 13. Challenges ahead for companion diagnostics.
    Schmidt C
    J Natl Cancer Inst; 2012 Jan; 104(1):14-5. PubMed ID: 22173588
    [No Abstract]   [Full Text] [Related]  

  • 14. Genomics, personalized medicine and cancer practice.
    Dancey J
    Clin Biochem; 2012 Apr; 45(6):379-81. PubMed ID: 22424082
    [No Abstract]   [Full Text] [Related]  

  • 15. Genomic research advances pancreatic cancer's early detection and treatment.
    Brower V
    J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 26142448
    [No Abstract]   [Full Text] [Related]  

  • 16. Refocusing the war on cancer: the critical role of personalized treatment.
    Potti A; Schilsky RL; Nevins JR
    Sci Transl Med; 2010 Apr; 2(28):28cm13. PubMed ID: 20410527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Locally advanced breast cancer (methods of treatment)].
    Portnoĭ SM
    Vopr Onkol; 2011; 57(5):553-8. PubMed ID: 22238923
    [No Abstract]   [Full Text] [Related]  

  • 18. Surrogate markers for targeted therapy-based treatment activity and efficacy.
    Bianchini G; Gianni L
    J Natl Cancer Inst Monogr; 2011; 2011(43):91-4. PubMed ID: 22043050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bridging the gap between translational research and clinical application.
    Miller WR; Larionov AA
    J Natl Cancer Inst Monogr; 2011; 2011(43):134-7. PubMed ID: 22043060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic alterations and personalized medicine in melanoma: progress and future prospects.
    Griewank KG; Scolyer RA; Thompson JF; Flaherty KT; Schadendorf D; Murali R
    J Natl Cancer Inst; 2014 Feb; 106(2):djt435. PubMed ID: 24511108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.